EMEA-001884-PIP03-18

Key facts

Active substance
Hydrogen Peroxide (45%)
Therapeutic area
Dermatology
Decision number
P/0268/2019
PIP number
EMEA-001884-PIP03-18
Pharmaceutical form(s)
Cutaneous solution
Condition(s) / indication(s)
Treatment of common warts (verrucae vulgaris)
Route(s) of administration
Cutaneous use
Contact for public enquiries
Aclaris Therapeutics, Inc.

Tel. +1 484 540 6264
E-mail: cmatkowski@aclaristx.com 

Decision type
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan

Decision

How useful was this page?

Add your rating